research

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis

Authors
    Publication date
    Publisher
    BioMed Central
    Doi

      Abstract

      Abstract is not available.

        Similar works

        Full text

        thumbnail-image

        Available Versions

        Springer - Publisher Connector

        redirect
        Last time updated on 03/05/2017